Background: Primary vaginal melanoma is a rare and highly malignant disease. The impact of therapy on outcomes is poorly understood.
Methods: Records of all patients treated for primary vaginal melanoma at Memorial Sloan-Kettering Cancer Center from 1977 to 2001 were reviewed.